Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476554
Status:
TERMINATED
Last Update Posted:
2021-12-22
First Post:
2007-05-19
Brief Title:
A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma
Sponsor:
Cyclacel Pharmaceuticals Inc
Organization:
Cyclacel Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cutaneous T-cell Lymphoma CTCL |
Keywords:
| Name | View |
|---|---|
| CTCL | View |